Ian Rabinowitz

2.3k total citations
48 papers, 1.3k citations indexed

About

Ian Rabinowitz is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ian Rabinowitz has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Hematology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ian Rabinowitz's work include Cancer Treatment and Pharmacology (9 papers), Blood groups and transfusion (7 papers) and Blood disorders and treatments (6 papers). Ian Rabinowitz is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Blood groups and transfusion (7 papers) and Blood disorders and treatments (6 papers). Ian Rabinowitz collaborates with scholars based in United States, United Kingdom and Canada. Ian Rabinowitz's co-authors include J Broomberg, Joseph Leong, Michael Goitein, J. Evan Sadler, Anna M. Randi, D J Mancuso, M. Bridget Zimmerman, Barbara F. Piper, Judith K. Payne and Claire F. Verschraegen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ian Rabinowitz

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian Rabinowitz United States	18	385	358	351	235	228	48	1.3k
George Shenouda Canada	24	637 1.7×	138 0.4×	688 2.0×	342 1.5×	75 0.3×	91	2.2k
Weiping Liu China	26	213 0.6×	276 0.8×	1.4k 4.1×	416 1.8×	85 0.4×	182	2.9k
Kazuo Kubota Japan	22	359 0.9×	100 0.3×	149 0.4×	356 1.5×	62 0.3×	106	1.6k
E Nordman Finland	16	565 1.5×	46 0.1×	482 1.4×	108 0.5×	102 0.4×	75	1.3k
Cristina Ferrari Italy	18	221 0.6×	180 0.5×	265 0.8×	448 1.9×	34 0.1×	99	1.2k
Elizabeth L. Travis United States	23	818 2.1×	106 0.3×	178 0.5×	306 1.3×	38 0.2×	42	1.9k
Ludwig Plaßwilm Switzerland	22	541 1.4×	93 0.3×	379 1.1×	286 1.2×	13 0.1×	96	1.6k
R. Härtung Germany	27	1.1k 2.8×	71 0.2×	229 0.7×	296 1.3×	71 0.3×	145	2.2k
Thomas Kearney United States	19	282 0.7×	35 0.1×	739 2.1×	342 1.5×	132 0.6×	39	1.9k
Henry G. Kaplan United States	22	325 0.8×	168 0.5×	831 2.4×	233 1.0×	113 0.5×	79	1.6k

Countries citing papers authored by Ian Rabinowitz

Since Specialization

Citations

This map shows the geographic impact of Ian Rabinowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Rabinowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Rabinowitz more than expected).

Fields of papers citing papers by Ian Rabinowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Rabinowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Rabinowitz. The network helps show where Ian Rabinowitz may publish in the future.

Co-authorship network of co-authors of Ian Rabinowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Rabinowitz. A scholar is included among the top collaborators of Ian Rabinowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Rabinowitz. Ian Rabinowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shaheen, Montaser, Julie Y. Tse, Ethan Sokol, et al.. (2022). Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial. eLife. 11. 9 indexed citations

Rabinowitz, Ian, et al.. (2020). Metastatic Pancreatic Cancer with BRAF and P53 Mutations: Case Report of Therapeutic Response to Doublet Targeted Therapy. Case Reports in Oncology. 13(3). 1239–1243. 16 indexed citations

Rabinowitz, Ian, et al.. (2017). Transient monoclonal gammopathy induced by Candida fungemia. Human Pathology. 75. 154–158. 2 indexed citations

Fajardo, Alexandra M., et al.. (2016). Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells. PLoS ONE. 11(3). e0151525–e0151525. 14 indexed citations

Rabinowitz, Ian, et al.. (2016). Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review. Cancer Genetics. 209(10). 481–485. 3 indexed citations

Bauman, Julie E., Claire F. Verschraegen, Steven A. Belinsky, et al.. (2014). A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers. Translational Oncology. 7(3). 349–354. 28 indexed citations

Murad, Waheed, Ian Rabinowitz, & Fa-Chyi Lee. (2014). Sorafenib-Induced Grade Four Hepatotoxicity in a Patient with Recurrent Gastrointestinal Stromal Tumor (GIST): A Case Report and Review of Literature. ACG Case Reports Journal. 1(2). 115–117. 7 indexed citations

Libby, Edward N., David García, M. Houman Fekrazad, et al.. (2014). Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups. Leukemia & lymphoma. 55(12). 2850–2857. 22 indexed citations

Verschraegen, Claire F., Hugo Arias‐Pulido, Sujana Movva, et al.. (2011). Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen. Annals of Oncology. 23(3). 785–790. 65 indexed citations

10.

Cristofanilli, Massimo, Vicente Valero, Aroop Mangalik, et al.. (2010). Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer. Clinical Cancer Research. 16(6). 1904–1914. 134 indexed citations

11.

Verschraegen, Claire F., et al.. (2010). A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer. American Journal of Clinical Oncology. 33(4). 393–397. 13 indexed citations

12.

Sayar, Hamid, et al.. (2010). Tumor MET Expression May Not Predict the Risk of Venous Thromboembolism in Cancer Patients. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(2). 93–97. 1 indexed citations

13.

Verschraegen, Claire F., Keith M. Skubitz, Adil Daud, et al.. (2008). A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 63(5). 903–910. 29 indexed citations

14.

Davis, Lisa M., Lei Tang, Peter Hraber, et al.. (2007). Amplification Patterns of Three Genomic Regions Predict Distant Recurrence in Breast Carcinoma. Journal of Molecular Diagnostics. 9(3). 327–336. 33 indexed citations

15.

Payne, Judith K., Barbara F. Piper, Ian Rabinowitz, & M. Bridget Zimmerman. (2006). Biomarkers, Fatigue, Sleep, and Depressive Symptoms in Women With Breast Cancer: A Pilot Study. Oncology nursing forum. 33(4). 775–783. 82 indexed citations

16.

Rabinowitz, Ian, Robert J. Telepak, & Fa-Chyi Lee. (2002). Octreotide Scans Are Positive in a Subset of Patients with Hepatocellular Carcinoma. Clinical Nuclear Medicine. 27(7). 499–502. 9 indexed citations

17.

Rabinowitz, Ian, et al.. (2002). Implementation and Results of a Test Dose Program with Taxanes. The Cancer Journal. 8(4). 337–341. 3 indexed citations

18.

Elias, Laurence, et al.. (1999). Factitious methemoglobinemia. American Journal of Hematology. 62(3). 196–197. 1 indexed citations

19.

Randi, Anna M., Ian Rabinowitz, D J Mancuso, Pier Mannuccio Mannucci, & J. Evan Sadler. (1991). Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.. Journal of Clinical Investigation. 87(4). 1220–1226. 94 indexed citations

20.

Rabinowitz, Ian, et al.. (1985). Accuracy of radiation field alignment in clinical practice. International Journal of Radiation Oncology*Biology*Physics. 11(10). 1857–1867. 235 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact